Ibusinus (Pseudoephedrine Hydrochloride, Ibuprofen)

Ibusinus combines a decongestant and an NSAID, acting on nasal passages and inflammatory pathways to relieve several common symptoms.

• Nasal congestion: reduces swelling of nasal mucosa, improving airflow.
• Headache: alleviates pain by decreasing prostaglandin‑mediated inflammation.
• Fever: lowers elevated body temperature through antipyretic action.
• Body pain: provides relief from mild to moderate musculoskeletal discomfort.

• Pseudoephedrine hydrochloride stimulates α‑adrenergic receptors in the nasal submucosa, causing vasoconstriction and decreased edema, while ibuprofen reversibly inhibits cyclo‑oxygenase‑1 and cyclo‑oxygenase‑2 enzymes, reducing prostaglandin synthesis that mediates pain, fever and inflammation. These mechanisms act systemically after oral absorption, reaching therapeutic concentrations within 30‑60 minutes, allowing prompt symptom control in acute upper‑respiratory conditions.

Ibusinus may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects

• Insomnia or difficulty sleeping.
• Nervousness or restlessness.
• Dry mouth or throat irritation.
• Nausea or mild stomach upset.
• Dizziness or light‑headedness.
• Headache.

Serious or Rare Side Effects

• Severe allergic reaction (anaphylaxis, rash, swelling).
• Gastrointestinal bleeding or ulceration.
• Elevated blood pressure or arrhythmia.
• Kidney function impairment.
• Liver enzyme elevation.
• Cardiovascular events such as myocardial infarction (rare).

Before using Ibusinus, consider the following precautions to ensure safe and effective use.

• Cardiovascular disease: avoid in patients with uncontrolled hypertension or severe heart disease.
• Gastrointestinal disorders: use with caution in those with a history of ulcers or bleeding.
• Renal impairment: dose adjustment may be needed for reduced kidney function.
• Pregnancy and breastfeeding: consult a healthcare professional before use.
• Drug allergies: do not take if allergic to pseudoephedrine, ibuprofen, or other NSAIDs.
• Store at ambient temperature: keep below 25 °C, in the original container, protected from moisture and direct sunlight.

Ibusinus can interact with other medicines; some combinations should be avoided while others require monitoring.

Major Interactions (Avoid)

• Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis.
• Anticoagulants (e.g., warfarin): increased bleeding risk from ibuprofen.
• Other sympathomimetics: may cause excessive cardiovascular stimulation.
• Selective serotonin reuptake inhibitors (SSRIs): heightened bleeding tendency.
• Lithium: pseudoephedrine may increase lithium levels.

Moderate Interactions (Monitor Closely)

• Diuretics: may enhance pseudoephedrine‑induced electrolyte changes.
• ACE inhibitors or ARBs: possible reduction in antihypertensive effect.
• Corticosteroids: additive risk of gastrointestinal irritation.
• Antiplatelet agents (e.g., aspirin): combined bleeding risk.
• Beta‑blockers: may blunt tachycardia response.